173 related articles for article (PubMed ID: 17141510)
1. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.
Hoepken HH; Gispert S; Morales B; Wingerter O; Del Turco D; Mülsch A; Nussbaum RL; Müller K; Dröse S; Brandt U; Deller T; Wirth B; Kudin AP; Kunz WS; Auburger G
Neurobiol Dis; 2007 Feb; 25(2):401-11. PubMed ID: 17141510
[TBL] [Abstract][Full Text] [Related]
2. Parkinson patient fibroblasts show increased alpha-synuclein expression.
Hoepken HH; Gispert S; Azizov M; Klinkenberg M; Ricciardi F; Kurz A; Morales-Gordo B; Bonin M; Riess O; Gasser T; Kögel D; Steinmetz H; Auburger G
Exp Neurol; 2008 Aug; 212(2):307-13. PubMed ID: 18511044
[TBL] [Abstract][Full Text] [Related]
3. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.
Sharma A; Kaur P; Kumar B; Prabhakar S; Gill KD
Parkinsonism Relat Disord; 2008; 14(1):52-7. PubMed ID: 18032086
[TBL] [Abstract][Full Text] [Related]
4. Sleep quality in a family with hereditary parkinsonism (PARK6).
Tuin I; Voss U; Kessler K; Krakow K; Hilker R; Morales B; Steinmetz H; Auburger G
Sleep Med; 2008 Aug; 9(6):684-8. PubMed ID: 17766179
[TBL] [Abstract][Full Text] [Related]
5. Enhanced vulnerability of PARK6 patient skin fibroblasts to apoptosis induced by proteasomal stress.
Klinkenberg M; Thurow N; Gispert S; Ricciardi F; Eich F; Prehn JH; Auburger G; Kögel D
Neuroscience; 2010 Mar; 166(2):422-34. PubMed ID: 20045449
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations and functions of PINK1.
Kawajiri S; Saiki S; Sato S; Hattori N
Trends Pharmacol Sci; 2011 Oct; 32(10):573-80. PubMed ID: 21784538
[TBL] [Abstract][Full Text] [Related]
7. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
Chinta SJ; Andersen JK
Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
[TBL] [Abstract][Full Text] [Related]
8. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
Kanwar M; Chan PS; Kern TS; Kowluru RA
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
[TBL] [Abstract][Full Text] [Related]
9. Overproduction of Cu/Zn-superoxide dismutase or Bcl-2 prevents the brain mitochondrial respiratory dysfunction induced by glutathione depletion.
Mérad-Saïdoune M; Boitier E; Nicole A; Marsac C; Martinou JC; Sola B; Sinet PM; Ceballos-Picot I
Exp Neurol; 1999 Aug; 158(2):428-36. PubMed ID: 10415149
[TBL] [Abstract][Full Text] [Related]
10. PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons.
Wang HL; Chou AH; Wu AS; Chen SY; Weng YH; Kao YC; Yeh TH; Chu PJ; Lu CS
Biochim Biophys Acta; 2011 Jun; 1812(6):674-84. PubMed ID: 21421046
[TBL] [Abstract][Full Text] [Related]
11. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain.
Kaur P; Radotra B; Minz RW; Gill KD
Neurotoxicology; 2007 Nov; 28(6):1208-19. PubMed ID: 17850875
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial translation initiation factor 3 gene polymorphism associated with Parkinson's disease.
Abahuni N; Gispert S; Bauer P; Riess O; Krüger R; Becker T; Auburger G
Neurosci Lett; 2007 Mar; 414(2):126-9. PubMed ID: 17267121
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
Büeler H
Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
[TBL] [Abstract][Full Text] [Related]
14. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
Verma R; Nehru B
Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
[TBL] [Abstract][Full Text] [Related]
15. Phylogenetic and in silico structural analysis of the Parkinson disease-related kinase PINK1.
Cardona F; Sánchez-Mut JV; Dopazo H; Pérez-Tur J
Hum Mutat; 2011 Apr; 32(4):369-78. PubMed ID: 21412950
[TBL] [Abstract][Full Text] [Related]
16. Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense.
Wen JJ; Vyatkina G; Garg N
Free Radic Biol Med; 2004 Dec; 37(11):1821-33. PubMed ID: 15528041
[TBL] [Abstract][Full Text] [Related]
17. Hereditary early-onset Parkinson's disease caused by mutations in PINK1.
Valente EM; Abou-Sleiman PM; Caputo V; Muqit MM; Harvey K; Gispert S; Ali Z; Del Turco D; Bentivoglio AR; Healy DG; Albanese A; Nussbaum R; González-Maldonado R; Deller T; Salvi S; Cortelli P; Gilks WP; Latchman DS; Harvey RJ; Dallapiccola B; Auburger G; Wood NW
Science; 2004 May; 304(5674):1158-60. PubMed ID: 15087508
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of mutations in PINK1 and mitochondrial DNA in early onset parkinsonism.
Piccoli C; Ripoli M; Quarato G; Scrima R; D'Aprile A; Boffoli D; Margaglione M; Criscuolo C; De Michele G; Sardanelli A; Papa S; Capitanio N
J Med Genet; 2008 Sep; 45(9):596-602. PubMed ID: 18524835
[TBL] [Abstract][Full Text] [Related]
19. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease.
Bharath S; Andersen JK
Antioxid Redox Signal; 2005; 7(7-8):900-10. PubMed ID: 15998245
[TBL] [Abstract][Full Text] [Related]
20. PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.
Wang HL; Chou AH; Yeh TH; Li AH; Chen YL; Kuo YL; Tsai SR; Yu ST
Neurobiol Dis; 2007 Nov; 28(2):216-26. PubMed ID: 17707122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
